Abstract: 10-Substituted 5-cyanomethylene-dibenzo[a,d]-cycloheptenes, their pure cis- and trans-isomers, their N-oxides and their pharmaceutically tolerated addition salts with acids, processes for their preparation, therapeutic agents containing these compounds and their use as drugs, especially as sedatives, hypnotics or tranquilizers.

Abstract: An ink fountain for a printing press has a temperature-responsive element for compensating the adjustment of the spacing between the blade and the fountain roller to keep the thickness of the ink film fed by the blade substantially constant even under extreme temperature variations. The sub-frame of the ink fountain is pivotally mounted to the main frame of the printing press about a pivot axis generally parallel to the axis of the fountain roller, and the pivot angle is a function of the thermal expansion of the temperature-responsive element. In one preferred embodiment, the temperature-responsive element is elongated, received in a guide fixed to the sub-frame, and has a free end bearing against the bearing bushing of the fountain roller. In another embodiment, the temperature-responsive element is a side wall of the ink trough or is a plate parallel to the side wall of the ink trough, and rollers are journaled to the temperature-responsive element and bear against the surface of the fountain roller.

Abstract: 5,6-Dihydro-11-methylenemorphanthridin-6-ones of the formula I ##STR1## where R.sup.1, R.sup.2, R.sup.3 and R.sup.4 have the meanings given in the description, and their preparation and use.The novel substances are particularly useful for treating gastric and duodenal ulcers.

Abstract: 10-Substituted 5-cyanomethylene-dibenzo[a,d]-cycloheptenes, their pure cis- and trans-isomers, their N-oxides and their pharmaceutically tolerated addition salts with acids, processes for their preparation, therapeutic agents containing these compounds and their use as drugs, especially as sedatives, hypnotics or tranquilizers.

Abstract: Novel (hetarylphenoxy)-(phenylpiperazinyl)-propanols of the formula ##STR1## where R.sup.1 is hydrogen, amino or alkyl of 1 to 4 carbon atoms, R.sup.2 is hydrogen, halogen, alkyl of 1 to 4 carbon atoms or alkoxy where alkyl is of 1 to 3 carbon atoms, the phenyl ring can be monosubstituted or disubstituted by R.sup.2, and the heterocyclic structure Het. is pyrimidinyl, triazol-1-yl, imidazol-1-yl, pyrazol-3-yl or isoxazol-3-yl, and their physiologically tolerated addition salts with acids, processes for their preparation, and pharmaceutical formulations which contain these compounds and exhibit predominantly hypotensive, sedative, neuroleptic and broncholytic properties.

Abstract: 6-Imidazol-1-yl-3-hydrazino-pyridazines, in which the imidazole ring is unsubstituted or is substituted by halogen or alkyl, their physiologically tolerated addition salts with acids, processes for their preparation and their use as drugs in the treatment of hypertonia.

Abstract: Novel 5,6-dihydro-11-alkylene-morphanthridin-6-ones of the formula ##STR1## where R.sup.1, R.sup.2, R.sup.3 and R.sup.4 have the meanings given in the description, their preparation and their use.The novel compounds are particularly useful in the treatment of gastric and duodenal ulcers.

Abstract: 6-Substituted 11-alkylene-morphanthridines, also referred to as 11-alkylene-dibenzo[b,e]-azepines, their pure cis- and trans-isomers, processes for their preparation, and therapeutic agents containing these compounds, which may be used as drugs, in particular neuroleptics, sedatives, hypnotics, analgesics, antidepressants or agents for treating Parkinson's syndrome.

Abstract: 10-Substituted 5-cyanomethylene-10,11-dihydro-dibenzo[a,d]-cycloheptenes, their pharmaceutically tolerated addition salts with acids, processes for their preparation, and their use as drugs, especially as sedatives, hypnotics or tranquilizers.

Abstract: 5-Substituted 9-cyanomethylene-dithieno[3,4-b:4',3'-e]-azepines, processes for their preparation, and therapeutic agents which contain these compounds and can be used as sedatives, hypnotic drugs, tranquillizers, neuroleptic drugs or anti-Parkinson drugs.

Abstract: 5,6-Dihydro-11-alkylene-morphanthridin-6-ones and processes for their preparation. The compounds are valuable intermediates for chemical syntheses, especially of drugs.